CMD Cantel Medical Corp

Cantel Medical Corp. reported Tuesday that profit for the final quarter of its fiscal year jumped 24%, helped by strong sales from its medivators endoscopy segment and recent acquisitions.

Shares of the company, which provides infection prevention and control products and services, increased 9.4% to $54.40 in midday trade.

Cantel Medical has focused its acquisition strategy on expanding its three major business segments—endoscopy, water purification and filtration, and health-care disposables. Additions last year include PuriCore International Ltd, International Medical Service S.r.l. and Sterilator Company Inc.

Chief Executive Andrew Krakauer said the company's double-digit sales growth highlights the success of the acquisitions, noting that all three of the company's business units have benefited from product development, sales and marketing programs, and integration of the recent acquisitions.

For the quarter ended in July, Cantel reported a profit of $13.3 million, or 32 cents a share, up from a year-earlier profit of $10.7 million, or 26 cents a share.

Revenue rose 15% to $151.4 million, helped by a jump of 27% in the medivators endoscopy segment.

Excluding certain items, the company posted per-share earnings for the quarter of 39 cents, up from 32 cents a year ago.

The company also announced that in September it acquired U.K.-based Medical Innovations Group Holdings Limited, a provider of endoscope storage and transport systems.

Write to Ezequiel Minaya at ezequiel.minaya@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

September 29, 2015 12:05 ET (16:05 GMT)

Copyright (c) 2015 Dow Jones & Company, Inc.